Ted Randolph is the Kenneth and Genevieve Gillespie Endowed Professor of bioengineering in the Department of Chemical and Biological Engineering and co-director of the Center for Pharmaceutical Biotechnology at CU Boulder. Randolph’s research focuses on stabilization of protein-based pharmaceuticals and led to the creation of spinoff companies RxKinetix, VitriVax and BaroFold Inc. He is a recipient of several distinguished awards including the Dale E. Wurster Research Award from the American Association of Pharmaceutical Scientists, which recognizes individuals who have made significant research contributions to the pharmaceutics field. Randolph joined the CU Boulder faculty in 1993 after several years at Yale University. He earned his PhD from UC Berkeley.